BALASUBRAMANIAN, SRIRAM,KUO, HSU-PING,HSIEH, HSIN-KANG,CHANG, BETTY,XUE, LING,CHEUNG, LEO
申请号:
CA2956550
公开号:
CA2956550A1
申请日:
2015.08.06
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
Disclosed herein are methods, compositions, and kits for treating a B-cell malignancy comprising administering a combination of a BTK inhibitor (e.g. ibrutinib) and a PIM inhibitor. Also disclosed herein are methods, compositions, and kits for treating a BTK-resistant B-cell malignancy comprising administering a combination of a BTK inhibitor (e.g. ibrutinib) and a PIM inhibitor.